Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help pharmaceutical leaders plan for success during their upcoming brand planning cycle.
It may not be as straightforward as it is in the realms of fast fashion or tourism, but influencer marketing, especially on social media, is still an attractive avenue in the pharma world.
The book launch for pharma industry veteran and award-winning businesswoman Merhnaz Campbell’s The Omni Advantage: Accelerating the Behavioural Change with Omnichannel in Pharma Sales E
In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commiss
In the first segment of Nine for 2024, we examined the continued fragility of healthcare systems, global pharmaceutical market infrastructure, and the journey to greater resilience.
Endeavor BioMedicines has completed a third-round financing, raising an impressive $132.5 million to fund trials of its two clinical-stage drug candidates for pulmonary fi
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.